Literature DB >> 6289278

Pro-opiocortin processing in the pituitary: a model for neuropeptide biosynthesis.

Y P Loh, H A Gritsch, T L Chang.   

Abstract

The biosynthesis of alpha-MSH, beta-endorphin and ACTH in the pituitary is reviewed. These neuropeptides are synthesized from a common pro-protein, pro-opiomelanocortin. The pro-protein is cleaved intragranularly, at pairs of basic residues in the molecule to yield the respective peptide products. An unique, thiol protease (pro-opiocortin converting enzyme) and a carboxypeptidase B-like enzyme, both localized within pituitary secretory granules and having a pH optimum of 5-6, appear to be involved in the proteolytic processing of pro-opiomelanocortin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6289278     DOI: 10.1016/0196-9781(82)90099-7

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  6 in total

Review 1.  Protein inhibitors of proteinases from brain.

Authors:  T Akopyan
Journal:  Neurochem Res       Date:  1991-05       Impact factor: 3.996

2.  Stress-induced peptide release from rat intermediate pituitary. An ultrastructural analysis.

Authors:  J A Carr; L C Saland; A Samora; S Desai; S Benevidez
Journal:  Cell Tissue Res       Date:  1990-09       Impact factor: 5.249

3.  Intragranular processing of pro-opiomelanocortin in the intermediate cells of the rat pituitary glands. A quantitative immunocytochemical approach.

Authors:  M Kalina; M Elmalek; I Hammel
Journal:  Histochemistry       Date:  1988

4.  Immunocytochemical evidence for intragranular processing of pro-opiomelanocortin in the melanotropic cells of the rabbit.

Authors:  M E Stoeckel; S Schimchowitsch; J C Garaud; G Schmitt; H Vaudry; M J Klein; A Porte
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

5.  The effect of bromocriptine on the intermediate lobe of the rat pituitary: an electron-microscopic, morphometric study.

Authors:  N Bäck
Journal:  Cell Tissue Res       Date:  1989-02       Impact factor: 5.249

6.  GIP_HUMAN[22-51] is a new proatherogenic peptide identified by native plasma peptidomics.

Authors:  Tsuguto Masaki; Yoshio Kodera; Michishige Terasaki; Kazumi Fujimoto; Tsutomu Hirano; Masayoshi Shichiri
Journal:  Sci Rep       Date:  2021-07-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.